Skip to content

Bridgewater Associates, LP: EQNR position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Bridgewater Associates, LP on EQNR, newest first. How the timeline and the estimate are built.

Bridgewater Associates, LP held 51,278 EQNR shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 51,278 shares
    Change vs previous 13F +11,923 shares

    0.01% of the 13F portfolio, value $1,610,129.

    13F-HR 0001350694-26-000003 filed by Bridgewater Associates, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 39,355 shares
    Change vs previous 13F -115,609 shares

    0.01% of the 13F portfolio, value $1,660,781.

    13F-HR 0001350694-26-000002 filed by Bridgewater Associates, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 154,964 shares
    Change vs previous 13F -129,656 shares

    0.01% of the 13F portfolio, value $3,661,799.

    13F-HR 0001350694-26-000001 filed by Bridgewater Associates, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 284,620 shares
    Change vs previous 13F -642,968 shares

    0.03% of the 13F portfolio, value $6,939,036.

    13F-HR 0001172661-25-004777 filed by Bridgewater Associates, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 927,588 shares
    Change vs previous 13F not available

    0.09% of the 13F portfolio, value $23,319,562.

    13F-HR 0001172661-25-003151 filed by Bridgewater Associates, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).